Naama Halevi-Davidov - 08 Feb 2023 Form 4 Insider Report for Gamida Cell Ltd.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 08 Feb 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Feb 2023, 18:34:51 UTC
Prior SEC filing: 24 Oct 2022
Next SEC filing: 20 Jun 2023
Source filing: View source filing
Reporting owner signature: /s/ Joshua F. Patterson, Attorney-in-Fact

Key filing fact

Naama Halevi-Davidov filed Form 4 for Gamida Cell Ltd. on 10 Feb 2023.

Key facts

This page summarizes Naama Halevi-Davidov's Form 4 filing for Gamida Cell Ltd..
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 10 Feb 2023, 18:34.

Change

Previous filing in this sequence was filed on 24 Oct 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GMDA transaction

Ordinary Shares

Award

Transaction value: $0
Shares: +28,300
Change %: +708%
Price: $0.000000
Shares after: 32,300
Date: 08 Feb 2023
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GMDA transaction Derivative

Share Option (Right to Buy)

Award

Transaction value: $0
Shares: +56,600
Change %
Price: $0.000000
Shares after: 56,600
Date: 08 Feb 2023
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 56,600
Exercise price: $1.59
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents a restricted share unit award, which shall vest on February 8, 2024, subject to the Reporting Person's continuous service through such vesting date.

Footnote F2

This option vests in equal quarterly installments over a twelve-month period, with the first such installment vesting on May 8, 2023, subject to the Reporting Person's continuous service through each such vesting date.